• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Pfizer Ventures

Photo of a paraglider passing tree-lined hills that are dark red from the leaves
Biotech

MHRA CEO Raine to depart in Autumn —Chutes & Ladders

Top UK medicines regulator to depart. New Pfizer Ventures chief starts. Ionis hires a familiar face for top strategy job.
Max Bayer , Annalee Armstrong Mar 1, 2024 9:30am
Nimbus clouds

Pfizer among investors raising Nimbus $125M for phase 3 launch

Sep 12, 2022 11:00am
genetic medicine Mrna dna

ReCode breaks the mold with $120M financing, Big Pharma backing

Jun 29, 2022 6:00am
Zurich Switzerland

Racing Sanofi, ImmunOs bags $74M for myeloid checkpoint trials

Jun 7, 2022 8:30am
venture capital funding

Lilly, Pfizer-backed Arkuda bags $64M to test drug in dementia

Feb 10, 2022 7:00am
Basel Switzerland

Pfizer, Novartis back $119M Anaveon series B for phase 2 trials

Dec 16, 2021 12:57pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings